EXHIBIT 3
---------
AGREEMENT
---------
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934,
the undersigned hereby agree that only one statement containing the information
required by Schedule 13D need be filed with respect to the ownership by each of
the undersigned of shares of stock of Essential Therapeutics, Inc.
EXECUTED this 2nd day of November, 2001.
NEW ENTERPRISE ASSOCIATES 10,
LIMITED PARTNERSHIP
By: NEA PARTNERS 10, LIMITED PARTNERSHIP
General Partner
By: *
------------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
General Partner
NEA PARTNERS 10, LIMITED PARTNERSHIP
By: *
------------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
General Partner
*
---------------------------------------------
▇▇▇▇▇▇▇ ▇▇▇▇▇
*
---------------------------------------------
M. ▇▇▇▇▇ ▇▇▇▇▇▇▇
*
---------------------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
*
---------------------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
*
---------------------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
*
---------------------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇
PAGE 1 OF 2
*
---------------------------------------------
C. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
*
---------------------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
*
---------------------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
*
---------------------------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ III
*
---------------------------------------------
▇▇▇▇ ▇. ▇▇▇▇▇
*
---------------------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
/s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
-----------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
As attorney-in-fact
This Schedule 13D was executed by ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ pursuant to a Power of
Attorney which is being filed with the Securities and Exchange Commission with
this Schedule 13D filing for Essential Therapeutics, Inc. and said Power of
Attorney is incorporated herein by reference and a copy of which is attached as
Exhibit 4.
PAGE 2 OF 2
